* Prominent players in the injectable drug delivery market are
The global injectable drug delivery market, valued at
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150
By Based on products, the formulations segment accounted for the largest market share in 2024, primarily due to the increased use of biologics. The rising prevalence of chronic diseases such as cancer, HIV, and obesity further fuels the growth of this market. The parenteral route of drug administration is considered ideal for biologics, as it enhances the bioavailability of therapeutic agents and maintains their stability. Additionally, a strong focus on research and development for targeted and controlled drug delivery drives market expansion. Long-acting and sustained-release formulations reduce dosing frequency, improving patient compliance. Innovations in injectable drug formulations, including the use of nanoparticles, micelles, and liposomes for targeted drug delivery, also contribute to market growth.
By formulation packaging, the ampoules segment is projected to grow at the highest CAGR within the formulation packaging sector. This growth can be attributed to the numerous advantages ampoules offer over other packaging options, such as vials. Ampoules are typically designed for single use, significantly reducing the risk of cross-contamination and ensuring accurate therapeutic product dosages. Additionally, they are more cost-effective than prefilled syringes, cartridge-based packaging, and vials. Glass ampoules are compatible with a wide range of therapeutic agents, including biologics, and help maintain their stability. Moreover, ampoules provide a longer shelf life for drugs and are easy to store.
By therapeutic application, the rapid growth of the obesity market segment is driven by the sedentary lifestyle of people worldwide. The high consumption of over-processed foods and various environmental factors significantly contribute to this trend. Additionally, genetic predisposition plays a role in the prevalence of this chronic condition.
Recent advancements in self-administration devices, such as autoinjectors and wearable technology, have made it easier for individuals to administer medication, especially in emergency situations. These devices provide options for at-home care, improving patient compliance. Furthermore, long-acting injectable formulations reduce the frequency of required medication dosages.
By site of administration, the dermal segment accounted for the largest market share in 2024. This segment encompasses both intradermal and subcutaneous routes of administration. The significant market share can be attributed to the ease of dermal-based administration, which is less invasive than intravenous routes. Dermal administration is also less painful and is typically preferred by patients who require frequent dosing for chronic conditions.
The subcutaneous route is particularly well-suited for self-administration devices, such as autoinjectors and pen injectors. In addition, needle-free injectors and microneedle devices are being developed for intradermal administration, which enhances patient compliance. Dermal-based injections are appropriate for a wide range of therapeutic products, including biologics, insulin, and vaccines.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=150
Prominent players in the injectable drug delivery market are
Media Contact
Company
Contact Person: Mr.
Email: newsletter@marketsandmarkets.com
Phone: 18886006441
Address:
City:
State:
Country:
Website: https://www.marketsandmarkets.com/Market-Reports/injectable-drug-delivery-market-150.html
Source: www.abnewswire.com
.
(C) 2025 M2 COMMUNICATIONS, source
